Tectonic Therapeutic, Inc (TECX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Tectonic Therapeutic, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Tectonic Therapeutic, Inc (TECX) has returned 48.18% so far this year and 74.53% over the past 12 months.

Based on dividend-adjusted daily data since Jun 21, 2018, TECX's average daily return is +0.07%, while the average monthly return is +0.11%. At this rate, your investment would double in approximately 52.5 years.

Historically, 49% of months were positive and 51% were negative. The best month was Jul 2023 with a return of +63.1%, while the worst month was Feb 2025 at -53.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.

On a daily basis, TECX closed higher 46% of trading days. The best single day was Jan 30, 2025 with a return of +113.2%, while the worst single day was Oct 1, 2018 at -51.6%.

Tectonic Therapeutic, Inc has an annualized alpha of -0.49%, beta of 1.30, and R² of 0.06 versus S&P 500 Index. Calculated based on daily prices since June 22, 2018.

• This stock participated in 196.36% of S&P 500 Index downside but only 78.51% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.06 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

TECX ranks 69 for risk / return — better than 69% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Tectonic Therapeutic, Inc (TECX) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Tectonic Therapeutic, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Tectonic Therapeutic, Inc was 98.90%, occurring on May 17, 2023. The portfolio has not yet recovered.

The current Tectonic Therapeutic, Inc drawdown is 95.11%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Tectonic Therapeutic, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Tectonic Therapeutic, Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.